Follow
Liquid Biopsy
A liquid biopsy is a diagnostic test using liquid biological samples. Considered non-invasive, it can be used to track cancers, heart issues, and do prenatal diagnosis.
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
NOV 19, 2025 | 9:00 AM
C.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
SEP 10, 2025 | 11:00 AM
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minima...
AUG 27, 2025 | 10:00 AM
C.E. CREDITS
Discover how global leaders are advancing equitable access to liquid biopsy with MSK-ACCESS® & SOPHiA DDM™ in this expert-led webinar....
July 31, 2025 7am PST/10am EST/4pm CET
microRNAs are emerging as powerful biomarkers for precision medicine, offering valuable insights into disease mechanisms, diagnosis, prognosis, and treatment response. However, successful di...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
MAY 20, 2025 | 10:00 AM
In this webinar, we expand on how the innovations of NovaSeq X are making multiomics a reality. We will highlight data from multi-project runs, massive single cell and CRISPR applications, a...
On Demand
LGC offers a comprehensive portfolio of reference standards and scientific tools for a wide range of disciplines. The focus of this talk will be on reference materials for clinical NGS produ...
APR 17, 2025 | 8:00 AM
This webinar explores cutting-edge advancements in ultra-deep circulating tumor DNA (ctDNA) sequencing, integrating artificial intelligence (AI) and precision oncology to address critical ch...
MAR 26, 2025 | 10:00 AM
C.E. CREDITS
The second webinar in the Precision Oncology Showcase series, sponsored by SOPHiA GENETICS, will highlight the successful decentralization of MSK-ACCESS® on the SOPHiA DDM™ Platfor...
MAR 12, 2025 | 8:00 PM
Liquid biopsy, a noninvasive method used for analysis of circulating biomarkers like tumor cells, DNA, and exosomes from bodily fluids, shows promise in advancing cancer research for future...
OCT 31, 2024 | 8:00 AM
Liquid biopsy next-generation sequencing (NGS) assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable or during disease progression. Extensiv...
SEP 19, 2024 | 10:00 AM
In the rapidly evolving field of oncology, precision medicine stands at the forefront of providing personalized patient care. Our upcoming webinar, "Transforming Oncology Diagnostics: I...
July 30, 2024 9am PDT, 11am CDT, 12pm EDT
Liquid Biopsy: Understand the significance of liquid biopsy in cancer research and the role of magnetic beads in sample preparation: After listening to the podcast, learners will be able to...
JUN 19, 2024 | 11:00 AM
Prof Pantel will give an introduction and review to the evolution of precision medicine and will then focus on the implementation of Liquid Biopsy in Precision Oncology....
JUN 18, 2024 | 9:00 AM
With the increasing number, complexity, and diversity of biomarkers to be tested in support of precision medicine approaches, limited tissue availability and patient health status can be bar...
MAY 15, 2024 | 12:00 PM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
